Literature DB >> 18257769

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults.

N Clumeck1, A Pozniak, F Raffi.   

Abstract

A working group of the European AIDS Clinical Society (EACS) have developed these guidelines for European clinicians to help them in the treatment of adults with HIV infection. This third version of the guidelines includes, as new topics, the assessment of patients at initial and subsequent clinic visits as well as post-exposure prophylaxis. A revision of the 2005 guidelines based on current data includes changes in the sections on primary HIV infection, when to initiate therapy, which drug combinations are preferred as initial combination regimens for antiretroviral-naïve patients, how to manage virological failure and the treatment of HIV during pregnancy. In Europe, there is a wide range of clinical practices in antiretroviral therapy depending on various factors such as drug registration, national policies, local availability, reimbursement and access to treatment. These can vary greatly from one country to another, especially in Central and Eastern parts of Europe. These guidelines are intended to help clinicians achieve the best care for their patients. In some countries, particularly where the quality of and access to care are not optimal, these guidelines should help AIDS societies and physicians or patient group organizations to negotiate with their national health authorities with a view to implementing what should be the standard of care for HIV-infected patients all over Europe.

Entities:  

Mesh:

Year:  2008        PMID: 18257769     DOI: 10.1111/j.1468-1293.2007.00533.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  67 in total

1.  Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp.

Authors:  Fan Wang; Ming-Xing Miao; Bin-Bin Sun; Zhong-Jian Wang; Xian-Ge Tang; Yang Chen; Kai-Jing Zhao; Xiao-Dong Liu; Li Liu
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  Antiretroviral therapeutic drug monitoring in Canada: current status and recommendations for clinical practice.

Authors:  Niamh Higgins; Alice Tseng; Nancy L Sheehan; Charles J L la Porte
Journal:  Can J Hosp Pharm       Date:  2009-11

3.  Clinical utility of genotypic resistance tests for HIV-1-infected patients with low-level virological failure.

Authors:  A Elgalib; M Perry; M Aboud; J Mullen; S O'Shea; I L Chrystie; R Kulasegaram; C Y W Tong
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

4.  Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.

Authors:  Alan Winston; Chris Duncombe; Patrick C K Li; John M Gill; Stephen J Kerr; Rebekah L Puls; Simon D Taylor-Robinson; Sean Emery; David A Cooper
Journal:  Neuroradiology       Date:  2012-07-07       Impact factor: 2.804

Review 5.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

6.  Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infection.

Authors:  Maximilian C Aichelburg; Julia Tittes; Florian Breitenecker; Thomas Reiberger; Norbert Kohrgruber; Armin Rieger
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

7.  HIV and liver disease forum: conference proceedings.

Authors:  Kenneth E Sherman; Marion Peters; Margaret James Koziel
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

8.  Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

Authors:  Asha R Kallianpur; Todd Hulgan
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

9.  Effective treatment of patients in a deep salvage situation with "non-active HAART": experiences with the expert advice system RADATA.

Authors:  T Lorenzen; I Walther; A Stoehr; B Salzberger; A Plettenberg
Journal:  Infection       Date:  2009-10-13       Impact factor: 3.553

10.  Optimizing initial therapy for HIV infection.

Authors:  Mark W Hull; Julio S G Montaner
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.